Tag: NASDAQ:NBIX

Stock Earnings

Neurocrine Biosciences, Inc [NBIX] Records 200-Day SMA of $133.47

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Neurocrine Biosciences,

Stock Earnings

Recent Insider Activity Suggests Potential Gains for Neurocrine Biosciences, Inc (NBIX)

In a filing, Neurocrine Biosciences, Inc revealed its Chief Corp. Affairs Officer Boyer David W. unloaded Company’s shares for reported

Stock Earnings

Neurocrine Biosciences, Inc [NBIX] stock for 421,828 USD was sold by Boyer David W.

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Insiders Updates

Raymond James gives an Outperform recommendation for Neurocrine Biosciences, Inc (NBIX)

In a filing, Neurocrine Biosciences, Inc revealed its Chief Corp. Affairs Officer Boyer David W. unloaded Company’s shares for reported

NUE

Insiders Updates

Taking a look at what insiders are doing to gauge the Neurocrine Biosciences, Inc (NBIX)’s direction

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Neurocrine Biosciences, Inc’s latest rating changes from various analysts

In a filing, Neurocrine Biosciences, Inc revealed its Chief Corp. Affairs Officer Boyer David W. unloaded Company’s shares for reported

Insiders Updates

Neurocrine Biosciences, Inc. [NBIX] Chief Corp. Affairs Officer makes an insider purchase of 3,461 shares worth 0.42 million.

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its

Analysts Viewpoint

Checking in on Neurocrine Biosciences, Inc. (NBIX) after recent insiders movement

Neurocrine Biosciences, Inc.’s recently made public that its Chief Corp. Affairs Officer Boyer David W. unloaded Company’s shares for reported

Analysts Viewpoint

A company insider recently sold 3,461 shares of Neurocrine Biosciences, Inc. [NBIX]. Should You Sale?

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or

Analysts Viewpoint

Neurocrine Biosciences, Inc. (NBIX) gets rating Resumed from Raymond James

Neurocrine Biosciences, Inc.’s recent filing unveils that its Chief Corp. Affairs Officer Boyer David W. unloaded Company’s shares for reported